% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • dinepat203 dinepat203 Dec 17, 2012 9:48 AM Flag

    PUMP & DUMP - EMA rejection and FDA soon... oligonucleotide all future research in Jeopardy.

    The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency today recommended that mipomersen (Kynamro, Isis and Genzyme) not be approved for use in Europe. The novel antisense ...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • A similar advisory commitee for the U.S. Food and Drug Administration recommended approval of the drug, called Kynamro, by a 9-6 vote in October. A report for the FDA committee said Kynamro carried health risks because it caused increased deposits of fat in the liver, a risk factor for cirrhosis and death

57.560.00(0.00%)Dec 21 4:00 PMEST